Breaking News
Get 40% Off 0
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list
Close

Hvivo PLC (HVO)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
27.52 -0.08    -0.29%
10:56:19 - Real-time Data. Currency in GBP ( Disclaimer )
  • Volume: 146,198
  • Bid/Ask: 27.20 / 28.00
  • Day's Range: 27.20 - 27.52
Type:  Equity
Market:  United Kingdom
ISIN:  GB00B9275X97 
SEDOL:  B9275X9
Hvivo 27.52 -0.08 -0.29%

Hvivo Company Profile

 
Read the Hvivo PLC company profile to learn more about the business and the management team. View Hvivo PLC facts about employee data, company products and services, and contact information.
IndustryBiotechnology & Medical Research
SectorHealthcare
Employees

218

Equity Type

ORD

hVIVO plc operates as a pharmaceutical service and contract research company. The company is involved in testing of vaccines and antivirals using human challenge clinical trials. It provides services to big pharma, biotech, government, and public health organizations. The company has a portfolio of human challenge study models for conditions, such as RSV, flu, human rhinovirus, asthma, malaria, cough, and COPD, as well as developing COVID-19 human challenge study model. In addition, it offers specialized virology and immunology laboratory, which offers a suite of services to support pre-clinical and clinical respiratory drug; and vaccine discovery and development. Further, the company provides preclinical and early clinical research services; sales and marketing services; data management; and statistics services, as well as drug development consultancy and services. The company was formerly known as Open Orphan Plc and changed its name to hVIVO plc in October 2022. hVIVO plc is headquartered in London, the United Kingdom.

Contact Information

Address 21 Plumbers Row
London, E1 1EQ
United Kingdom
Phone 44 20 7756 1300
Fax -

Top Executives

Name Age Since Title
Elaine Sullivan 60 2020 Independent Non-Executive Director
John Oxford - 2020 Chair of Advisory Board
Michael Meade 60 2020 Independent Non-Executive Director
Brendan Buckley 71 - Member of Advisory Board & Non-Executive Director
Martin John Gouldstone 55 2022 Independent Non-Executive Director
Yamin Mohammed Khan 52 2021 CEO & Director
Stephen Pinkerton - 2022 CFO & Executive Director
Cathal Martin Friel 58 2020 Chairman of the Board
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

HVO Price Commentary

Write your thoughts about Hvivo PLC
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Bernard Potluri
Potlucky Oct 20, 2020 10:34
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Great news! Huge potential. Buying opportunity IMO DYOR
Bernard Potluri
Potlucky Jul 13, 2020 14:11
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Excellent presentation by Executive Chairman 11/6/20: https://www.openorphan.com/sites/openorphan-v2/files/2020-06/Open_Orphan_Investor_Presentation-June_2020_3.pdf HUGE  potential. DYOR!
Paul Mott
Paul Mott Jun 04, 2020 10:20
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Open Orphan launches “best-in-class" coronavirus testing service 2020-06-04 07:53:00
Santana Deniro
Santana Deniro Jun 04, 2020 10:20
Saved. See Saved Items.
This comment has already been saved in your Saved Items
whats goin on
paul barnbrook
paul barnbrook May 22, 2020 9:25
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Nigel i do like ORPH but i think they are a little to far behind the likes of Genedrive,and today they have the  CE Mark to start selling to the world.Plus ORPH have just had a Placing which will hold them back as it did with Gnedrive 2 weeks ago. good luck
Nigel King
Nigel King May 22, 2020 9:25
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Cheers Paul i think it is interesting times for both companies .I still dont think folk understand what ORPH are about
paul barnbrook
paul barnbrook Apr 25, 2020 16:10
Saved. See Saved Items.
This comment has already been saved in your Saved Items
i looked at them but genedrive got my vote after many hours of research
Nigel King
Nigel King Apr 25, 2020 16:10
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Interesting Paul ,good luck
Nigel King
Nigel King Apr 25, 2020 16:10
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Paul i think ORPH is a sleeping giant.
Nigel King
Nigel King Apr 25, 2020 16:10
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Good morning Paul any views on share price .Genedrive on my radar .
Nigel King
Nigel King Feb 03, 2020 9:22
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Anybody following ORPH
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email